Hormone-like steroids in children with Tourette syndrome
Studies steroid hormone patterns in boys and girls with Tourette syndrome.
Key facts
- Who runs it
- University of Utah
- Where
- Salt Lake City, United StatesSee the site
- Trial code
- Registry title
- Exploring the Role of Neuroactive Steroids in Tourette Syndrome
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 15 May 2023
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional
- Treatments tested
- Tic suppression task
- Record updated
- 6 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 8 to 12 with Tourette syndrome, a condition with tics. It also takes children without any tic disorder as a comparison group.
- Age
- 8 to 12 years
- Sex
- Boys and girls
- Disease stage
- Children with tics must have a diagnosis of Tourette syndrome. Comparison children must have no tic disorder.
- Earlier treatment
- Children cannot join if they use therapies that can change hormone levels. They also cannot join if they take drugs that may change stress sensitivity, such as antidepressants and anxiolytics.
- Biomarker or test result
- Sexual development must be confirmed by a parent and/or by self-reported Tanner stage of pubic hair development.
Main reasons for not taking part
- Major psychiatric disorders, such as psychotic disorder, autism spectrum disorder, conduct disorder or substance use disorder
- Other neurological disorders
- Clinically significant hormone (endocrine) disorders
- Use of therapies that can change hormone levels
- Drugs that may change stress sensitivity, such as antidepressants and anxiolytics
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Diagnostic criteria of TS for cases (and lack of any tic disorders for controls)
- Age between 8 and 12 years old (this age range is to ensure that TS participants can perform the tic suppression task)
- confirmation of sexual development by parent and/or self-reported Tanner stage of pubic hair development
Who cannot take part
- use of therapies that can modify hormonal profile
- major psychiatric disorders such as a psychotic disorder, autism spectrum disorder, conduct disorder, and substance use disorder
- other neurological disorders
- clinically significant endocrinological disorders
- pharmacotherapies that may change stress sensitivity, such as antidepressants and anxiolytics
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 12 years old?
Where in United States
- University of UtahSalt Lake City, United StatesContact: Michael Himle, PhDTaking people
About the trial
What the trial wants to find out
Tourette syndrome (TS) is a disabling neurodevelopmental disorder characterized by motor and phonic tics. The studies proposed in this application will explore the endocrine mechanisms underlying two of the least well-understood biological characteristics of TS, namely its marked male predominance and stress susceptibility. In particular, our exploratory studies will characterize the steroid profile in TS-affected boys and girls to identify novel potential biomarkers and therapeutic targets for this disorder.
The group in the trial
- Tic suppressionTreatment being tested
Children with tics will undergo a tic suppression experimental paradigm.
Treatment: Tic suppression task
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exploring the Role of Neuroactive Steroids in Tourette Syndrome
- Plain-language title
- Hormone-like steroids in children with Tourette syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05281445, who can take part
- Record updated
- 6 October 2026